METHODS	The effects of iloprost infusion on plasminogen activator inhibitor type-1 ( PAI-1 ) , glucometabolic control and cardiovascular equilibrium in patients with type-2 diabetes mellitus and peripheral arterial occlusive disease were investigated .\